Lilly in-licenses Axiron

Acrux Ltd. (ASX:ACR) granted Eli Lilly and Co. (NYSE:LLY) exclusive, worldwide rights to commercialize Axiron, a testosterone metered-dose lotion that is applied to the underarm to treat hypogonadism....